Performance of 0.55T MRI is comparable to 1.5T MRI in acquiring and interpreting late gadolinium enhancement in patients suspected of myocardial infarction, research shows.
A lower-field strength MRI can provide effective cardiac imaging for patients who have suspected or known myocardial infarction, a new pilot study has demonstrated.
In a poster presentation submitted to the International Society of Magnetic Resonance in Medicine virtual annual meeting, a team of cardiology investigators from the National Institutes of Health (NIH) described their use of 0.55T MRI to acquire and interpret late gadolinium enhancement (LGE) in possible heart attack patients.
Because high-field strength MRI has been known to increase artifact in cardiac imaging, there is a push to develop low-field cardiac MRI, the team said.
“Our group has demonstrated that a lower field strength, paired with the high-performance hardware and contemporary imaging software, may be well suited to cardiac imaging,” said the team led by W. Patricia Bandettini, M.D., associate research physician at the NIH. “Our pilot investigation demonstrates that demanding imaging techniques, such as late gadolinium enhancement imaging, are feasible at 0.55T.”
Successful implementation of this approach could not only reduce costs, the team said, but it could also increase accessibility to cardiac MR imaging.
To determine the comparative difference between both types of imaging strengths, the team assessed 13 patients for known or suspected myocardial infarction with both 0.55T and 1.5T MRI. The investigators intravenously administered gadobutrol and performed LGE imaging after 10 minutes.
For imaging analysis, LGE sequences selected and optimized for each field strength on a 17-segment model. They used the identification of abnormal LGE consistent with myocardial infarction, as well as additional grading of the coronary distribution – whether the myocardial infarction was less than or more than 50 percent transmural extent – for scoring.
According to their evaluations, the number of segments identified between each field strength was comparable. The 0.55T scanner identified 59 segments with myocardial infarction (50 subendocardial and nine transmural), and the 1.5T scanner detected 63 segments with myocardial infarction (53 subendocardial and 10 transmural). In addition, the team said, epicardial coronary artery distribution matched exactly between the two field strengths.
The team plans to expand their work with future studies that include free-breathing acquisition methods.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.